As the delta form of the virus continues to spread, US authorities say transplant patients and those with highly compromised immune systems may get an additional dosage of the Pfizer or Moderna COVID-19 vaccinations to protect them against infection further.
Several million Americans are affected by the Food and Drug Administration’s late-night warning on Thursday. These individuals are particularly susceptible because they have had organ transplants, have certain malignancies, or have other illnesses. There are comparable suggestions from several other nations, including France and Israel.
Before The Weekend, The FDA May Approve A COVID Booster For Vulnerable Adults
Due to the difficulty of revving up an immune system that certain medications or diseases have suppressed, those patients do not always receive the same level of protection as healthy people, and small studies suggest that an additional dose may be the solution for some of them. According to US authorities on Thursday, transplant patients and others with weaker immune systems may get an extra dosage of the COVID-19 vaccine to protect them as the delta variant’s prevalence increases.
We know that Texans are experiencing the effects of the coronavirus at levels that have never been seen before in the state’s history. This is why our detectives are interested in hearing from you. We are seeking information on a variety of subjects to assist us in our investigation of the challenges and solutions surrounding this epidemic.
Have you been fired from your job? Investigate our coverage of unemployed people filing complaints. Is a loved one confined to a nursing home? Are you a member of the healthcare team? Do you know anybody who has died as a result of acquiring the virus? Do you have concerns about the safety of your neighborhood? Have you ever had a problem with testing delays? Check out our full coverage, as well as other resources. Please share your tale with us.
We recognize that this is a delicate and personal matter, and we will respect your wishes if you prefer that your identity be kept confidential. Because of organ transplants, some malignancies, and other illnesses, the Food and Drug Administration’s decision will affect millions of Americans who are particularly susceptible to the effects of the disease. There are comparable suggestions from several other nations, including France and Israel.
An immunocompromised adolescent from the Austin region is waiting for FDA clearance for a COVID-19 booster injection. Because it is more difficult for vaccines to rev up an immune system that certain medications or diseases have suppressed, those patients do not always receive the same level of protection as healthy people, and small studies propose that for some of them, an additional dose may be the answer. Before the FDA’s announcement, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said that the agency’s move was intended to ensure that the most vulnerable people in society were better safeguarded from COVID-19.
Notably, the judgment only applies to this high-risk category of people in the United States, accounting for about 3 percent of the population. It does not imply that the general public will be eligible for booster dosages. Instead, health officials regard the additional dosage as a component of the original COVID-19 vaccination prescription for immunocompromised individuals. Separately, US health officials are continuing to closely monitor whether and when the average person’s immunity begins to wane to the point where boosters are required for everyone but for the time being, the vaccines continue to provide robust protection for the general population, according to the CDC.